Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-24T21:51:30.727Z Has data issue: false hasContentIssue false

Chapter 2 - Risk Factors

from Section 1 - Epidemiology, Risk Factors, Pathophysiology, and Causes of Transient Ischemic Attacks and Stroke

Published online by Cambridge University Press:  01 August 2018

Gary K. K. Lau ,
Sarah T. Pendlebury  and
Peter M. Rothwell
Gary K. K. Lau
Affiliation:
University of Oxford
Sarah T. Pendlebury
Affiliation:
University of Oxford
Peter M. Rothwell
Affiliation:
University of Oxford
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Transient Ischemic Attack and Stroke
Diagnosis, Investigation and Treatment
 , pp. 17 - 34
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aburto, NJ, Ziolkovska, A, Hooper, L et al. (2013). Effect of lower sodium intake on health: Systematic review and meta-analyses. British Medical Journal 346:f1326CrossRefGoogle ScholarPubMed
Adler, AJ, Taylor, F, Martin, N et al. (2014). Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 12:CD009217Google Scholar
Allport, LE, Parsons, MW, Butcher, KS et al. (2005). Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology 65:1382–1387CrossRefGoogle ScholarPubMed
Amarenco, P, Bogousslavsky, J, Callahan, A III et al. (2006). High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine 355:549–559Google Scholar
Amarenco, P, Labreuche, J (2009). Lipid management in the prevention of stroke: Review and updated meta-analysis of statins for stroke prevention. Lancet Neurology 8:453–463Google Scholar
Atrial Fibrillation Investigators (1994). Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Archives of Internal Medicine 154:1449–1457Google Scholar
Atrial Fibrillation Investigators (1998). Echocardiographic predictors of stroke in patients with atrial fibrillation. Archives of Internal Medicine 158:1316–1320Google Scholar
Baigent, C, Keech, A, Kearney, PM et al. (2005). Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90 056 participants in 14 randomized trials of statins. Lancet 66:1267–1278Google Scholar
Bamford, J, Sandercock, PAG, Dennis, M et al. (1990). A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981–86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. Journal of Neurology, Neurosurgery and Psychiatry 53:16–22Google Scholar
Bhatia, M, Rothwell, PM (2005). A systematic comparison of the published data available on risk factors for stroke, compared with risk factors for coronary heart disease. Cerebrovascular Diseases 20:180–186Google Scholar
Birns, J, Markus, H, Kalra, L (2005). Blood pressure reduction for vascular risk: Is there a price to be paid? Stroke 36:1308–1313Google Scholar
Blackshear, JL, Safford, RE (2003). AFFIRM and RACE trials: Implications for the management of atrial fibrillation. Cardiology Electrophysiology Review 7:366–369Google Scholar
Bonaa, KH, Njlstad, I, Ueland, PM et al. (2006). Homocysteine lowering and cardiovascular events after acute myocardial infarction. New England Journal of Medicine 354:1578–1588Google Scholar
Bousser, MG, Kittner, SJ (2000). Oral contraceptives and stroke. Cephalagia 20:183–189Google Scholar
Brass, LM, Hartigan, PM, Page, WF et al. (1996). Importance of cerebrovascular disease in studies of myocardial infarction. Stroke 27:1173–1176Google ScholarPubMed
Brunner, E, Davey Smith, G, Marmot, M et al. (1996). Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 347:1008–1013Google Scholar
Byar, DP, Corle, DK (1988). Hormone therapy for prostate cancer: Results of the Veterans Administration Cooperative Urological Research Group Studies. NCI Monographs 7:165–170Google Scholar
Chang, CL, Donaghy, M, Poulter, N et al. (1999). Migraine and stroke in young women: Case–control study. British Medical Journal 318:13–18CrossRefGoogle ScholarPubMed
Clarke, R, Lewington, S, Youngman, L et al. (2002). Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age. European Heart Journal 23:286–293Google Scholar
Collins, R, Armitage, J, Parish, S et al. (2004). Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions. Lancet 363:757–767Google Scholar
Dahlof, B, Devereux, RB, Kjeldsen, SE et al. (2002). Cardiovascular morbidity and mortality in Losartan Intervention For End Point Reduction in Hypertension (LIFE) study: A randomized trial against atenolol. Lancet 359:995–1003Google Scholar
Danesh, J, Collins, R, Peto, R (1997). Chronic infections and coronary heart disease: Is there a link? Lancet 350:430–436Google Scholar
Danesh, J, Youngman, L, Clark, S et al. (1999). Helicobacter pylori infection and early onset myocardial infarction: Case–control and sibling pairs study. British Medical Journal 319:1157–1162Google Scholar
Danesh, J, Whincup, P, Walker, M et al. (2000). Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis. British Medical Journal 321:208–213Google Scholar
Danesh, J, Whincup, P, Walker, M (2003). Chlamydia pneumoniae IgA titres and coronary heart disease: Prospective study and meta-analysis. European Heart Journal 24:881Google Scholar
Danesh, J, Lewington, S, Thompson, SG et al. (2005). Plasma fibrinogen level and the risk of major cardiovascular diseases and non-vascular mortality: An individual participant meta-analysis. Journal of American Medical Association 294:1799–1809Google Scholar
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2003). Intensive diabetes therapy and carotid intima-media thickness in type I diabetes mellitus. New England Journal of Medicine 346:393–403Google Scholar
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2005). Intensive diabetes treatment and cardiovascular disease in patients with type I diabetes. New England Journal of Medicine 353:2643–2653CrossRefGoogle Scholar
Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 346:393–403Google Scholar
di Pasquale, G, Urbinati, S, Pinelli, G (1995). New echocardiographic markers of embolic risk in atrial fibrillation. Cerebrovascular Diseases 5:315–322Google Scholar
Donaghy, M, Chang, CL, Poulter, N et al. (2002). European Collaborators of the World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Duration, frequency, recency, and type of migraine and the risk of ischemic stroke in women of childbearing age. Journal of Neurology, Neurosurgery and Psychiatry 73:747–750CrossRefGoogle Scholar
Ducros, A (2012). Reversible cerebral vasoconstriction syndrome. Lancet Neurology 11:906–917Google Scholar
Dusitanond, P, Eikelboom, JW, Hankey, GJ et al. (2005). Homocysteine-lowering treatment with folic acid, cobalamin and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction or hypercoagulability in patients with previous transient ischemic attack or stroke: A randomized substudy of the VITATOPS trial. Stroke 36:144–146Google Scholar
Eastern Stroke and Coronary Heart Disease Collaborative Research Group (1998). Blood pressure, cholesterol and stroke in Eastern Asia. Lancet 352:1801–1807Google Scholar
Eckel, RH, Grundy, SM, Zimmet, PZ (2005). The metabolic syndrome. Lancet 365:1415–1428Google Scholar
Elkind, MS, Sciacca, R, Boden-Albala, B et al. (2006). Moderate alcohol consumption reduces risk of ischemic stroke: The Northern Manhattan Study. Stroke 37:13–19CrossRefGoogle ScholarPubMed
Endres, M, Heuschmann, PU, Laufs, U et al. (2011). Primary prevention of stroke: Blood pressure, lipids, and heart failure. European Heart Journal 32:545–552Google Scholar
Estruch, R, Ros, E, Salas-Salvadó, J et al. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine 368:1279–1290Google Scholar
Fagerberg, B, Gnarpe, J, Gnarpe, H et al. (1999). Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: A prospective study in middle-aged to elderly men with treated hypertension. Stroke 30:299–305Google Scholar
Feigin, VL, Wiebers, DO, Nikitin, YP et al. (1998). Risk factors for ischemic stroke in a Russian community: A population-based case–control study. Stroke 29:34–39Google Scholar
Feigin, VL, Rinkel, GJ, Lawes, CM et al. (2005). Risk factors for subarachnoid hemorrhage: An updated systematic review of epidemiological studies. Stroke 36:2773–2780Google Scholar
Feigin, VL, Roth, GA, Naghavi, et al. (2016). Global burden of stroke and risk factors in 188 countries, during 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurology 15:913–924Google Scholar
Fine-Edelstein, JS, Wolf, PA, O’Leary, et al. (1994). Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 44:1046–1050CrossRefGoogle ScholarPubMed
Friberg, L, Rosenqvist, M, Lip, GY et al. (2012). Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study. European Heart Journal 33:1500–1510Google Scholar
Gil-Nunez, AC, Vivancos-Mora, J (2005). Blood pressure as a risk factor for stroke and the impact of antihypertensive treatment. Cerebrovascular Diseases 20:40–52Google Scholar
GISSI-Prevenzione Investigators (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 354:447–455Google Scholar
Glader, CA, Stegmayr, B, Boman, J et al. (1999). Chlamydia pneumoniae antibodies and high lipoprotein (a) levels do not predict ischemic cerebral infarctions: Results from a nested case–control study in northern Sweden. Stroke 30:2013–2018Google Scholar
Goldstein, LB, Hankey, GJ (2006). Advances in primary stroke prevention. Stroke 37:317–319Google Scholar
Grau, AJ, Buggle, F, Becher, H et al. (1998). Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: Clinical and biochemical studies. Neurology 50:196–203Google Scholar
Grau, AJ, Becher, H, Ziegler, CM et al. (2004). Periodontal disease as a risk factor for ischemic stroke. Stroke 35:396–501Google Scholar
Grodstein, F, Manson, JE, Colditz, GA et al. (2000). A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Annals of Internal Medicine 133:922–941Google Scholar
Grundy, SM, Cleeman, JI, Daniels, SR et al. (2005). Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart Lung and Blood Institute Scientific Statement. Circulation 112:2735–2752Google Scholar
Gutiérrez, OM, Judd, SE, Muntner, P et al. (2012). Racial differences in albuminuria, kidney function, and risk of stroke. Neurology 79:1686–1692CrossRefGoogle ScholarPubMed
Haapanen, A, Koskenvuo, M, Kaprio, J et al. (1989). Carotid arteriosclerosis in identical twins discordant for cigarette smoking. Circulation 80:10–16Google Scholar
Hankey, GJ (2002). Is homocysteine a causal and treatable risk factor for vascular diseases of the brain (cognitive impairment and stroke). Annals of Neurology 51:279–281Google Scholar
Hankey, GJ, Eikelboom, JW (2005). Homocysteine and stroke. Lancet 365:194–196Google Scholar
Harman, SM, Black, DM, Naftolin, F et al. (2014). Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: A randomized trial. Annals of Internal Medicine 161:249–260Google Scholar
Harmsen, P, Rosengren, A, Tsipogiannia, A et al. (1990). Risk factors for stroke in middle-aged men in Goteborg Sweden. Stroke 21:223–229Google Scholar
Hart, RG, Benavente, O, McBride, R et al. (1999). Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Annals of Internal Medicine 131:492–501Google Scholar
Hart, RG, Halperin, JL, Pearce, LA et al. (2003). Lessons from the Stroke Prevention in Atrial Fibrillation trials. Annals of Internal Medicine 138:831–838Google Scholar
He, FJ, MacGregor, GA (2004). The effect of longer-term modest salt reduction on blood pressure. Cochrane Database of Systematic Reviews 1:CD004937Google Scholar
He, FJ, Nowson, CA, MacGregor, GA (2006). Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies. Lancet 367:320–326Google Scholar
He, K, Song, Y, Daviglus, ML et al. (2004). Fish consumption and incidence of stroke: A meta-analysis of cohort studies. Stroke 35:1538–1542Google Scholar
Heart Protection Study Collaborative Group (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomized placebo-controlled trial. Lancet 360:7–22Google Scholar
Hemelaar, M, van der Mooren, M, Rad, M et al. (2008). Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: A systematic review. Fertility and Sterility 90:642–672Google Scholar
Hodis, HN, Mack, WJ, Henderson, VW et al. (2016). Vascular effects of early versus late postmenopausal treatment with estradiol. New England Journal of Medicine 374:1221–1231Google Scholar
Hollander, M, Hak, AE, Koudstaal, PJ et al. (2003). Comparison between measures of atherosclerosis and risk of stroke: The Rotterdam Study. Stroke 34:2367–2372Google Scholar
Homer, D, Ingall, TJ, Baker, HL et al. (1991). Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension. Mayo Clinic Proceedings 66:259–267Google Scholar
Hooper, L, Capps, N, Clements, G et al. (2004). Foods or supplements rich in omega-3 fatty acids for preventing cardiovascular disease in patients with ischemic heart disease. Cochrane Database of Systematic Reviews 4:CD003177Google Scholar
Hooper, L, Capps, N, Clements, G et al. (2008). Anti-oxidant foods or supplements for preventing cardiovascular disease. Cochrane Database of Systematic Reviews 3:CD001558Google Scholar
Howard, G, Wagenknecht, LE, Burke, GL et al. (1998). Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. Journal of the American Medical Association 279:119–124Google Scholar
Hsieh, SW, Lai, CL, Liu, CK et al. (2012). Obstructive sleep apnea liked to wake-up strokes. Journal of Neurology 259:1433–1439Google Scholar
Huxley, R, Lewington, S, Clarke, R (2002). Cholesterol, coronary heart disease and stroke: A review of published evidence from observational studies and randomized controlled trials. Seminars in Vascular Medicine 2:315–323CrossRefGoogle ScholarPubMed
Jackson, C, Sudlow, C (2005). Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and non-lacunar infarcts. Stroke 36:891–901Google Scholar
Jespersen, CM, Als-Nielsen, B, Damgaard, M et al. (2006). Randomized placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial. British Medical Journal 332:22–27Google Scholar
Jorgensen, HS, Nakayama, H, Raaschou, HO et al. (1994). Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 25:1977–1984Google Scholar
Julius, S, Kjeldsen, SE, Weber, M et al. (2004). Outcomes in hypertensive patients at high cardiovascular risk, treated with regimens based on valsartan or amlodipine: The VALUE randomized trail. Lancet 363:2022–2031CrossRefGoogle ScholarPubMed
Kearney, PM, Welton, M, Reynolds, K et al. (2005). Global burden of hypertension: Analysis of worldwide data. Lancet 365:217–223Google Scholar
Keli, S, Bloemberg, B, Kromhout, D (1992). Predictive value of repeated systolic blood pressure measurements for stroke risk. The Zutphen Study. Stroke 23:347–351Google Scholar
Kernan, WN, Viscoli, CM, Furie, KL et al. (2016). Pioglitazone after ischemic stroke or transient ischemic attack. New England Journal of Medicine 374:1321–1331Google Scholar
Khaw, KT, Barrett-Connor, E (1987). Dietary potassium and stroke-associated mortality. A 12-year prospective population study. New England Journal of Medicine 316:235–240Google Scholar
Koren-Morag, N, Tanne, D, Graff, E et al. (2002). Low and high density lipoprotein, cholesterol and ischemic cerebrovascular disease. The Bezafibrate Infarction Prevention Registry. Archives of International Medicine 162:993–999Google Scholar
Krause, DN, Duckles, SP, Pelligrino, DA (2006). Influence of sex steroid hormones on cerebrovascular function. Journal of Applied Physiology 101:1252–1261Google Scholar
Lee, CD, Folsom, AR, Blair, SN (2003). Physical activity and stroke risk. A meta-analysis. Stroke 34:2475–2482Google Scholar
Lee, M, Saver, JL, Chang, KH et al. (2010). Low glomerular filtration rate and risk of stroke: Meta-analysis. British Medical Journal 341:c4249Google Scholar
Leppala, JM, Virtamo, J, Fogelholm, R et al. (2000). Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arteriosclerosis, Thrombosis and Vascular Biology 20:230–235Google Scholar
Lewington, S, Clarke, R (2005). Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk. Circulation 112:3373–3374Google Scholar
Lewington, S, Clarke, R, Qizilbash, N et al. (2002). Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913Google Scholar
Leys, D, Woimant, F, Ferrieres, J et al. (2006). Detection and management of associated atherothrombotic locations in patients with a recent atherothrombotic ischemic stroke: Results of the DETECT survey. Cerebrovascular Diseases 21:60–66CrossRefGoogle ScholarPubMed
Lip, GY (2005). Atrial fibrillation (recent onset). Clinical Evidence 14:71–89Google Scholar
Lip, GY, Boos, CJ (2006). Antithrombotic treatment in atrial fibrillation. Heart 92:155–161Google Scholar
Lip, GY, Hee, FL (2001). Paroxysmal atrial fibrillation. Quarterly Journal of Medicine 94:665–678Google Scholar
Lip, GY, Nieuwlaat, R, Pisters, R et al. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272Google Scholar
Lisabeth, L, Bushnell, C (2012). Stroke risk in women: The role of menopause and hormone therapy. Lancet Neurology 11:82–91Google Scholar
Lovelock, CE, Molyneux, AJ, Rothwell, PM for the Oxford Vascular Study (2007). Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: A population-based study. Lancet Neurology 6:487–493Google Scholar
Lowe, GDO, Lee, AJ, Rumley, A et al. (1997). Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study. British Journal of Haematology 96:168–173Google Scholar
MacMahon, S, Peto, R, Cutler, J et al. (1990). Blood pressure, stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 335:765–774Google Scholar
Macko, RF, Kittner, SJ, Epstein, A et al. (1999). Elevated tissue plasminogen activator, antigen and stroke risk. The Stroke Prevention in Young Women Study. Stroke 30:7–11Google Scholar
Markus, HS, Hambley, H (1998). Neurology and the blood: Haematological abnormalities in ischemic stroke. Journal of Neurology, Neurosurgery and Psychiatry 64:150–159CrossRefGoogle Scholar
Markus, HS, Mendall, MA (1998). Helicobacter pylori infection: A risk factor for ischemic cerebrovascular disease and carotid atheroma. Journal of Neurology, Neurosurgery and Psychiatry 64:104–107Google Scholar
Matthews, K, Crawford, S, Chae, C et al. (2009). Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? Journal of the American College of Cardiology 54:2366–2373Google Scholar
McCullough, LD, Alkayed, NJ, Traystman, RJ et al. (2001). Postischemic estrogen reduces hypoperfusion and secondary ischemic after experimental stroke. Stroke 32:796–802Google Scholar
Meade, TW, Ruddock, V, Stirling, Y et al. (1993). Fibrinolytic activity, clotting factors and long-term incidence of ischemic heart disease in the Northwick Park Heart Study. Lancet 342:1076–1079Google Scholar
Mendelsohn, M, Karas, R (2005). Molecular and cellular basis of cardiovascular genetic differences. Science 308:1583–1587Google Scholar
Nattel, S, Opie, L (2006). Controversies in atrial fibrillation. Lancet 367:262–272Google Scholar
Ngeh, J, Gupta, S, Goodbourn, C et al. (2003). Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): A case–control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovascular Diseases 15:11–16Google Scholar
Ninomiya, T, Perkovic, V, Verdon, C et al. (2009). Proteinuria and stroke: a meta-analysis of cohort studies. American Journal of Kidney Diseases 53:417–425Google Scholar
O’Donnell, MJ, Chin, SL, Rangarajan, S et al. (2016). Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet 388:761–775Google Scholar
Pendlebury, ST (2007). Worldwide under-funding of stroke research. International Journal of Stroke 2:80–84Google Scholar
Petrovitch, H, Curb, D, Bloom-Marcus, E (1995). Isolated systolic hypertension and risk of stroke in Japanese-American men. Stroke 26:25–29Google Scholar
Prospective Studies Collaboration (1995). Cholesterol, diastolic blood pressure and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet 346:1647–1653CrossRefGoogle Scholar
Qizilbash, N, Duffy, S, Prentice, CRM et al. (1997). Von Willebrand factor and risk of ischemic stroke. Neurology 49:1552–1556Google Scholar
Reeves, MJ, Bushnell, CD, Howard, G et al. (2008). Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurology 7:915–926Google Scholar
Renoux, C, Dell’aniello, S, Garbe, E et al. (2010). Transdermal and oral hormone replacement therapy and the risk of stroke: A nested case-control study. British Medical Journal 340:c2519Google Scholar
Reynolds, K, Lewis, B, Nolen, JD et al. (2003). Alcohol consumption and risk of stroke: A meta-analysis. Journal of the American Medical Association 289:579–588Google Scholar
Rodgers, A, MacMahon, S, Gamble, G et al. (1996). Blood pressure and risk of stroke in patients with cerebrovascular disease. British Medical Journal 313:147Google Scholar
Rothwell, PM (2001). The high cost of not funding stroke research: A comparison with heart disease and cancer. Lancet 19:1612–1616Google Scholar
Rothwell, PM (2005). Prevention of stroke in patients with diabetes mellitus and the metabolic syndrome. Cerebrovascular Diseases 1:24–34Google Scholar
Rothwell, PM, Howard, SC, Spence, D (2003). Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 34:2583–2590Google Scholar
Rothwell, PM, Coull, AJ, Giles, MF et al. (2004a). Change in stroke incidence, mortality, case-fatality, severity and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363:1925–1933Google Scholar
Rothwell, PM, Howard, SC, Power, DA et al. (2004b). Fibrinogen and risk of ischemic stroke and coronary events in 5183 patients with transient ischemic attack and minor ischemic stroke. Stroke 35:2300–2305Google Scholar
Rothwell, PM, Coull, AJ, Silver, LE et al. (2005). Population-based study of event-rate, incidence, case fatality and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366:1773–1783Google Scholar
Rothwell, PM, Howard, SC, Dolan, E et al. (2010). Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375:895–905Google Scholar
Rundek, T, Gardener, H, Xu, Q et al. (2010). Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Archives of Neurology 67:1195–1200Google Scholar
Sacco, RL (2001). Newer risk factors for stroke. Neurology 57:S31–S34Google Scholar
Sagie, A, Larson, MG, Levy, D (1993). The natural history of borderline isolated systolic hypertension. New England Journal of Medicine 329:1912–1917Google Scholar
Sandercock, PAG, Bamford, J, Dennis, M et al. (1992). Atrial fibrillation and stroke: Frequency in different stroke types and influence on early and long term prognosis. The Oxfordshire Community Stroke Project. British Medical Journal 305:1460–1465Google Scholar
Sare, GM, Gray, LJ, Bath, PM (2008). Association between hormone replacement therapy and subsequent arterial and venous vascular events: A meta-analysis. European Heart Journal 29:2031–2041Google Scholar
Saxonhouse, SJ, Curtis, AB (2003). Risks and benefits of rate control versus maintenance of sinus rhythm. American Journal of Cardiology 91:27D–32DGoogle Scholar
Schulz, UG, Rothwell, PM (2003). Differences in vascular risk factors between aetiological subtypes of ischemic stroke in population-based incidence studies. Stroke 34:2050–2059Google Scholar
Segal, JB, McNamara, RL, Miller, MR et al. (2001). Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Cochrane Database Systematic Reviews 1:CD001938Google Scholar
Shah, RS, Cole, JW (2010). Smoking and stroke: The more you smoke the more you stroke. Expert Review of Cardiovascular Therapy 8:917–932Google Scholar
Shaper, AG, Phillips, AN, Pocock, SJ et al. (1991). Risk factors for stroke in middle-aged British men. British Medical Journal 302:1111–1115Google Scholar
Sifat, AE, Vaidya, B, Villalba, H et al. (2017). E-cigarette exposure alters brain glucose utilization and stroke outcome. Abstract at International Stroke Conference 2017Google Scholar
Steinberg, D (1995). Clinical trials of antioxidants in atherosclerosis: Are we doing the right thing? Lancet 346:36–38Google Scholar
Stemmermann, GN, Hayashi, T, Resch, JA et al. (1984). Risk factors related to ischemic and hemorrhagic cerebrovascular disease at autopsy: The Honolulu Heart Study. Stroke 15:23–28Google Scholar
Stephens, N (1997). Anti-oxidant therapy for ischemic heart disease: Where do we stand? Lancet 349:1710–1711Google Scholar
Stevens, RJ, Coleman, RL, Adler, AI et al. (2004). Risk factors for myocardial infarction, case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care 27:201–207Google Scholar
Strachan, DP, Carrington, D, Mendall, MA et al. (1999). Relation of Chlamydia pneumoniae serology to mortality and incidence of ischemic heart disease over 13 years in the Caerphilly Prospective Heart Disease Study. British Medical Journal 318:1035–1039Google Scholar
Stroke Prevention in Atrial Fibrillation Investigators (1992). Predictors of thromboembolism in atrial fibrillation: II Echocardiographic features of patients at risk. Annals of Internal Medicine 116:6–12Google Scholar
Stroke Prevention in Atrial Fibrillation Investigators (1995). Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The Stroke Prevention in Atrial Fibrillation Study. Journal of Stroke and Cerebrovascular Disease 5:147–157Google Scholar
Suk, SH, Sacco, RL, Boden-Albala, B et al. (2003). Abdominal obesity and risk of ischemic stroke: The Northern Manhattan Stroke Study. Stroke 34:1586–1592Google Scholar
Sundell, L, Salomaa, V, Vartiainen, E et al. (2008). Increased stroke risk is related to a binge drinking habit. Stroke 39:3179–3184Google Scholar
Toole, JF, Malinow, MR, Chambless, LE et al. (2004). Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. Journal of the American Medical Association 291:565–575Google Scholar
Touzé, E, Warlow, CP, Rothwell, PM (2006). Risk of coronary and other nonstroke vascular death in relation to the presence and extent of atherosclerotic disease at the carotid bifurcation. Stroke 37:2904–2909Google Scholar
Toyoda, K, Ninomiya, T (2014). Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurology 13:823–833Google Scholar
Tuomilehto, J, Rastenyte, D (1999). Diabetes and glucose intolerance as risk factors for stroke. Journal of Cardiovascular Risk 6:241–249Google Scholar
Tuomilehto, J, Lindstrom, J, Erikkson, JG et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 344:1343–1350Google Scholar
UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin, compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853Google Scholar
Wald, DS, Law, M, Morris, JK (2002). Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. British Medical Journal 325:1202–1206Google Scholar
Wald, DS, Law, M, Morris, JK (2004). The dose–response relationship between serum homocysteine and cardiovascular disease: Implications for treatment and screening. European Journal of Cardiovascular Prevention and Rehabilitation 11:250–253Google Scholar
Wang, X, Qin, X, Demirtas, H et al. (2007). Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 369:1876–1882Google Scholar
Wannamethee, SG, Shaper, AG, Whincup, PH (1995). Smoking cessation and the risk of stroke in middle-aged men. Journal of American Medical Association 274:155–160Google Scholar
Wannamethee, SG, Perry, IJ, Shaper, AG (1999). Non-fasting serum glucose and insulin concentrations and the risk of stroke. Stroke 30:1780–1786Google Scholar
Welin, L, Svardsudd, K, Wilhelmsen, L et al. (1987). Analysis of risk factors for stroke in a cohort of men born in 1913. New England Journal of Medicine 317:521–526Google Scholar
Westover, AN, McBride, S, Haley, RW. (2007). Stroke in young adults who abuse amphetamines or cocaine: A population-based study of hospitalized patients. Archives of General Psychiatry 64:495–502Google Scholar
Whelton, PK, He, J, Cutler, JA et al. (1997). Effects of oral potassium on blood pressure: Meta-analysis of randomized controlled clinical trials. Journal of the American Medical Association 277:1624–1632Google Scholar
Wolf, PA, D’Agostino, RB, Belanger, AJ et al. (1991). Probability of stroke: A risk profile from the Framingham Study. Stroke 22:312–318Google Scholar
Wolff, V, Armspach, JP, Lauer, V et al. (2013). Cannabis-related stroke: Myth or reality? Stroke 44:558–563Google Scholar
Yaggi, HK, Concato, J, Kernan, WN et al. (2005). Obstructive sleep apnea as a risk factor for stroke and death. New England Journal of Medicine 353:2034–2041Google Scholar
Yiin, GS, Howard, DP, Paul, NL et al. (2014). Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: A population-based study. Circulation 130:1236–1244Google Scholar
Yusuf, S, Phil, D, Sleight, DM et al. (2000). Effects of an angiotensin-coverting-enzyme inhibitor ramipril on cardiovascular events in high-risk patients. New England Journal of Medicine 342:145–153Google Scholar
Zhang, X, Patel, A, Horibe, H et al. (2003). Cholesterol coronary heart disease and stroke in the Asia Pacific region. International Journal of Epidemiology 32:563–572Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×